Cartherics Enters Agreement with Uniquest, The University of Queensland and The University of Sydney For Advancing Innovative Cardiac Cellular Therapy
Posted: 29 July 2024 Cartherics Pty Ltd (“Cartherics” or “Company”), a biotechnology company developing immune cell therapies for the treatment of cancer, is pleased to announce that it has entered into a Technology Licence Agreement (TLA) with The…
FDA Accepts Telix NDA for New Prostate Cancer Imaging Agent
Posted: 29 July 2024 Telix today announces that the United States (U.S.) Food and Drug Administration (FDA) has accepted the filing of its New Drug Application (NDA) for TLX007-CDx, a new and proprietary cold kit (“Kit”) for the…
Alterity Therapeutics Reports Positive Interim Data from ATH434-202 Phase 2 Clinical Trial in Multiple System Atrophy
Posted: 23 July 2024 Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced positive interim data from the ATH434-202 open-label Phase 2 clinical…
Dr Liriye Kurtovic awarded Moderna Global Fellowship 2023
Posted: 23 July 2024 Burnet Senior Research Officer Dr Liriye Kurtovic has been awarded a Moderna Global Fellowship to support her research into the development of a new malaria vaccine. The coveted fellowship supports scientists and healthcare professionals…
Immutep Announces Successful Meeting with FDA on Phase III Design in Non-Small Cell Lung Cancer
Posted: 23 July 2024 Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a clinical-stage biotechnology company developing novel LAG-3 immunotherapies for cancer and autoimmune disease, today announces that positive feedback has been received from the US…
Rapid drug test to provide patients with better care
Posted: 23 July 2024 Teams at two of Melbourne’s leading research and medical institutes are developing high-tech solutions to rapidly test for drugs and better treat patients presenting to hospital. The researchers from the Colonial Foundation Healthy Ageing Centre –…
Breakthrough in high-performance computing and quantum chemistry revolutionises drug discovery
Posted: 23 July 2024 A breakthrough in high-performance computing (HPC) and quantum chemistry, powered by the world’s fastest supercomputer and leading technology, is set to revolutionise drug discovery and unlock new ways to target a range of diseases.…
Why early life antibiotic use can increase risk of asthma: a potential prevention for asthma later in life?
Posted: 23 July 2024 Early exposure to antibiotics can trigger long term susceptibility to asthma, according to new research from Monash University. Importantly the research team isolated a molecule produced by gut bacteria that in the future could…
Immutep Receives Regulatory Clearance for Phase I Study of First-in-Class LAG-3 Agonist Antibody Designed to Treat Autoimmune Diseases
Posted: 23 July 2024 Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a clinical-stage biotechnology company developing novel LAG-3 immunotherapies for cancer and autoimmune disease, today announces it has received regulatory clearance from the ethics and…
Melbourne merger for a united vision and stronger Victoria
Posted: 16 July 2024 We are delighted to announce that Committee for Melbourne and Melbourne Chamber of Commerce intend to come together to create a stronger voice to advocate for the future of Greater Melbourne. The expanded Committee…
Optiscan Receives Ethical Clearance for Breast Cancer Study
Posted: 16 July 2024 Optiscan Imaging Limited (ASX:OIL) (‘Optiscan’ or ‘The Company’) is pleased to announce that it has received ethical clearance from the Royal Melbourne Hospital Human Research Ethics Committee to undertake an in vivo clinical study…
Hub opens opportunities for new disease treatments
Posted: 16 July 2024 A new treatment that could potentially reverse or stop progression of traumatic brain injury will be developed at a new state-of-the-art biotechnology facility launched at La Trobe University. The $8 million Bio Innovation Hub,…
